While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Over-exposure to an allergen also raises the risk of allergies, says David Cor ry, MD, professor of medicine in the section ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

A board-certified immunologist clears the air—turns out, there's only one time when allergies can lead to a fever.

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play ...

AbbVie and Neomorph are set to enter a partnership and option-to-license agreement to develop molecular glue degraders.

Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Dozens of Alberta scientists, doctors and researchers have penned an open letter calling on the Alberta government to reject ...

In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.